| Overview |
| bsm-62908r-rbitc-100ul |
| MEF2C Recombinant Antibody, RBITC Conjugated |
| WB, IF |
| Human, Rat |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human MEF2C |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4208 |
| Q06413 |
| Nucleus |
| C5DELq14.3; DEL5q14.3; MEF2C. |
| Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. Enhances transcriptional activation mediated by SOX18. Plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz